Company creates Younger T Cells for fighting cancer using its NR2F6 technology
Orion to receive an upfront payment of USD 290 million
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
